|
|
Average five-year survival rate for pancreatic cancer patients, up from 3% in 1975-77; 24% of patients survive one year after diagnosis. Overall, median survival is 4 to 6 months. But prognosis depends on the stage and type of disease: patients with neuroendocrine and cystic tumors, for instance, have much better survival rates than do patients with pancreatic adenocarcinoma. [via Medscape]
The same anesthetic that caused the overdose death of pop star Michael Jackson is now the drug of choice for executions in Missouri, causing a stir among critics who question how the state can guarantee a drug untested for lethal injection won’t cause pain and suffering for the condemned.
A new study finds that babies born by c-section are twice as likely to be obese by age 3 as those delivered vaginally.
Tuberculosis has been brought under control in much of the world, thanks to prevention practices and powerful antibiotics. But in poor nations like Peru, the disease still kills hundreds of babies and children — and new drug-resistant cases threaten an even bigger resurgence.
